Current Data About
Item Q28145831
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P50) |
(Q110167848)
|
||||||||||||||||
| (P304) |
69-79
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
1
|
||||||||||||||||
| (P478) |
107
|
||||||||||||||||
| (P577) |
+1999-10-00T00:00:00Z
|
||||||||||||||||
| (P921) |
(Q29496)
(Q145)
|
||||||||||||||||
| (P1433) |
(Q4970200)
|
||||||||||||||||
| (P1476) |
"A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties" (language: en)
|
||||||||||||||||
| (P2093) |
K Wheatley
A K Burnett
R G Gray
I M Hann
C J Harrison
J K Rees
R F Stevens
H Walker
|